This Platelet Rich Plasma market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.
The platelet rich plasma market size has grown rapidly in recent years. It will grow from $0.71 billion in 2024 to $0.83 billion in 2025 at a compound annual growth rate (CAGR) of 17.4%. The growth in the historic period can be attributed to rising demand for minimally invasive procedures, rising prevalence of chronic conditions such as arthritis, growing focus on pain management and injury recovery, increasing adoption of PRP in veterinary medicine, rising disposable income and healthcare expenditure.
The platelet rich plasma market size is expected to see rapid growth in the next few years. It will grow to $1.57 billion in 2029 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to growing prevalence of sports injuries, increasing incidence of orthopedic disorders, rising demand for cosmetic and aesthetic procedures, aging population and related increase in age-related conditions, growing number of clinical trials supporting PRP efficacy. Major trends in the forecast period include technological advancements in platelet-rich plasma processing systems, new recent developments, emergence of new applications of platelet-rich plasma therapy, ongoing research and innovation, increasing investments.
The growing prevalence of sports injuries is expected to drive the expansion of the platelet-rich plasma (PRP) market. This increase in injuries can be attributed to factors such as higher participation in sports, greater enrollment in youth sports programs, age-related considerations, and insufficient coaching and supervision. PRP therapy plays a key role in sports injury recovery by promoting tissue repair and regeneration, reducing inflammation, and enhancing the healing of tendons and ligaments, offering athletes a minimally invasive treatment that may lead to quicker recovery times. For example, in November 2023, Howden Group Holdings Ltd, a UK-based insurance intermediary, reported that 88 injuries in October 2022 led to an average of 11.35 days of sidelined players before a tournament, whereas in January 2023, after the tournament, this figure rose to 19.41 days. The report also highlighted a significant rise in the severity of injuries to the ankle, calf/shin, and hamstring, with increases of 170%, 200%, and 130%, respectively. Therefore, the growing incidence of sports injuries is fueling the growth of the PRP market.
Leading companies in the PRP market are focusing on developing off-the-shelf plasma products to meet the increasing demand for PRP treatments, particularly in the aesthetics sector. Off-the-shelf PRP products provide a convenient solution for therapeutic use, offering consistent platelet dose and potency without the need for individual preparation. For example, 4T Medical launched a labeled PRP kit in July 2023, designed to prepare autologous PRP for promoting skin rejuvenation and efficient healing. The kit includes anticoagulant test tubes and necessary consumables for blood drawing, facilitating the identification and injection of PRP to enhance healing, collagen production, skin tightening, and hair growth.
In March 2023, Kedaara Capital acquired a majority stake in Oliva Skin & Hair Clinic, aiming to support Oliva's growth in becoming India's leading aesthetic dermatology player with a pan-India reach. Oliva Skin & Hair Clinic provides PRP hair treatment solutions, aligning with the growing demand for PRP therapies in the aesthetics and dermatology sectors.
Major companies operating in the platelet rich plasma market are Johnson & Johnson Services Inc., Stryker, Zimmer Biomet, Terumo Corporation, Arthrex Inc., Pall Corporation, Globus Medical, LifeNet Health, Exactech Inc., BioBridge Global, Regen Lab SA, Celling Biosciences Inc., Eclipse Aesthetics LLC, Regenexx, Isto Biologics, Royal Biologics, Apex Biologix, EmCyte Corporation, Medira Ltd., Nuo Therapeutics Inc., Juventix Regenerative Medical LLC., Estar Medical, Dr PRP USA LLC, MDBiologix, Vivostat A/S.
North America was the largest region in the platelet-rich plasma market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet rich plasma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the platelet rich plasma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Platelet-rich plasma (PRP) is a concentrated form of plasma that contains platelets, growth factors, and bioactive proteins. It is obtained from the patient's own blood through centrifugation, which separates the platelets from other blood components. PRP finds use in medical and cosmetic treatments because of its healing and tissue regeneration properties.
The primary variations of platelet-rich plasma include pure platelet-rich plasma, leukocyte-rich platelet-rich plasma, leukocyte-rich fibrin, among others. Pure platelet-rich plasma denotes a concentrated solution of platelets and plasma, devoid of red and white blood cells, thus ensuring heightened platelet-derived growth factors. It can be sourced from allogeneic, autologous, or homologous platelet-rich plasma for applications in cosmetic surgery, aesthetics, general surgery, neurosurgery, orthopedic and spinal surgery, and other medical uses, utilized by hospitals, clinics, research institutes, and other end-users.
The platelet rich plasma market research report is one of a series of new reports that provides platelet rich plasma market statistics, including the platelet rich plasma industry global market size, regional shares, competitors with platelet rich plasma market share, detailed platelet rich plasma market segments, market trends, and opportunities, and any further data you may need to thrive in the platelet rich plasma industry. These platelet rich plasma market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The platelet-rich plasma market includes revenues earned by entities by providing PRP hair restoration, skin rejuvenation, acne scar treatment, orthopedic treatments, post-surgical healing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The platelet rich plasma market size has grown rapidly in recent years. It will grow from $0.71 billion in 2024 to $0.83 billion in 2025 at a compound annual growth rate (CAGR) of 17.4%. The growth in the historic period can be attributed to rising demand for minimally invasive procedures, rising prevalence of chronic conditions such as arthritis, growing focus on pain management and injury recovery, increasing adoption of PRP in veterinary medicine, rising disposable income and healthcare expenditure.
The platelet rich plasma market size is expected to see rapid growth in the next few years. It will grow to $1.57 billion in 2029 at a compound annual growth rate (CAGR) of 17.2%. The growth in the forecast period can be attributed to growing prevalence of sports injuries, increasing incidence of orthopedic disorders, rising demand for cosmetic and aesthetic procedures, aging population and related increase in age-related conditions, growing number of clinical trials supporting PRP efficacy. Major trends in the forecast period include technological advancements in platelet-rich plasma processing systems, new recent developments, emergence of new applications of platelet-rich plasma therapy, ongoing research and innovation, increasing investments.
The growing prevalence of sports injuries is expected to drive the expansion of the platelet-rich plasma (PRP) market. This increase in injuries can be attributed to factors such as higher participation in sports, greater enrollment in youth sports programs, age-related considerations, and insufficient coaching and supervision. PRP therapy plays a key role in sports injury recovery by promoting tissue repair and regeneration, reducing inflammation, and enhancing the healing of tendons and ligaments, offering athletes a minimally invasive treatment that may lead to quicker recovery times. For example, in November 2023, Howden Group Holdings Ltd, a UK-based insurance intermediary, reported that 88 injuries in October 2022 led to an average of 11.35 days of sidelined players before a tournament, whereas in January 2023, after the tournament, this figure rose to 19.41 days. The report also highlighted a significant rise in the severity of injuries to the ankle, calf/shin, and hamstring, with increases of 170%, 200%, and 130%, respectively. Therefore, the growing incidence of sports injuries is fueling the growth of the PRP market.
Leading companies in the PRP market are focusing on developing off-the-shelf plasma products to meet the increasing demand for PRP treatments, particularly in the aesthetics sector. Off-the-shelf PRP products provide a convenient solution for therapeutic use, offering consistent platelet dose and potency without the need for individual preparation. For example, 4T Medical launched a labeled PRP kit in July 2023, designed to prepare autologous PRP for promoting skin rejuvenation and efficient healing. The kit includes anticoagulant test tubes and necessary consumables for blood drawing, facilitating the identification and injection of PRP to enhance healing, collagen production, skin tightening, and hair growth.
In March 2023, Kedaara Capital acquired a majority stake in Oliva Skin & Hair Clinic, aiming to support Oliva's growth in becoming India's leading aesthetic dermatology player with a pan-India reach. Oliva Skin & Hair Clinic provides PRP hair treatment solutions, aligning with the growing demand for PRP therapies in the aesthetics and dermatology sectors.
Major companies operating in the platelet rich plasma market are Johnson & Johnson Services Inc., Stryker, Zimmer Biomet, Terumo Corporation, Arthrex Inc., Pall Corporation, Globus Medical, LifeNet Health, Exactech Inc., BioBridge Global, Regen Lab SA, Celling Biosciences Inc., Eclipse Aesthetics LLC, Regenexx, Isto Biologics, Royal Biologics, Apex Biologix, EmCyte Corporation, Medira Ltd., Nuo Therapeutics Inc., Juventix Regenerative Medical LLC., Estar Medical, Dr PRP USA LLC, MDBiologix, Vivostat A/S.
North America was the largest region in the platelet-rich plasma market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the platelet rich plasma market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the platelet rich plasma market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Platelet-rich plasma (PRP) is a concentrated form of plasma that contains platelets, growth factors, and bioactive proteins. It is obtained from the patient's own blood through centrifugation, which separates the platelets from other blood components. PRP finds use in medical and cosmetic treatments because of its healing and tissue regeneration properties.
The primary variations of platelet-rich plasma include pure platelet-rich plasma, leukocyte-rich platelet-rich plasma, leukocyte-rich fibrin, among others. Pure platelet-rich plasma denotes a concentrated solution of platelets and plasma, devoid of red and white blood cells, thus ensuring heightened platelet-derived growth factors. It can be sourced from allogeneic, autologous, or homologous platelet-rich plasma for applications in cosmetic surgery, aesthetics, general surgery, neurosurgery, orthopedic and spinal surgery, and other medical uses, utilized by hospitals, clinics, research institutes, and other end-users.
The platelet rich plasma market research report is one of a series of new reports that provides platelet rich plasma market statistics, including the platelet rich plasma industry global market size, regional shares, competitors with platelet rich plasma market share, detailed platelet rich plasma market segments, market trends, and opportunities, and any further data you may need to thrive in the platelet rich plasma industry. These platelet rich plasma market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The platelet-rich plasma market includes revenues earned by entities by providing PRP hair restoration, skin rejuvenation, acne scar treatment, orthopedic treatments, post-surgical healing. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Platelet Rich Plasma Market Characteristics3. Platelet Rich Plasma Market Trends and Strategies4. Platelet Rich Plasma Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Platelet Rich Plasma Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Platelet Rich Plasma Market34. Recent Developments in the Platelet Rich Plasma Market
5. Global Platelet Rich Plasma Growth Analysis and Strategic Analysis Framework
6. Platelet Rich Plasma Market Segmentation
7. Platelet Rich Plasma Market Regional and Country Analysis
8. Asia-Pacific Platelet Rich Plasma Market
9. China Platelet Rich Plasma Market
10. India Platelet Rich Plasma Market
11. Japan Platelet Rich Plasma Market
12. Australia Platelet Rich Plasma Market
13. Indonesia Platelet Rich Plasma Market
14. South Korea Platelet Rich Plasma Market
15. Western Europe Platelet Rich Plasma Market
16. UK Platelet Rich Plasma Market
17. Germany Platelet Rich Plasma Market
18. France Platelet Rich Plasma Market
19. Italy Platelet Rich Plasma Market
20. Spain Platelet Rich Plasma Market
21. Eastern Europe Platelet Rich Plasma Market
22. Russia Platelet Rich Plasma Market
23. North America Platelet Rich Plasma Market
24. USA Platelet Rich Plasma Market
25. Canada Platelet Rich Plasma Market
26. South America Platelet Rich Plasma Market
27. Brazil Platelet Rich Plasma Market
28. Middle East Platelet Rich Plasma Market
29. Africa Platelet Rich Plasma Market
30. Platelet Rich Plasma Market Competitive Landscape and Company Profiles
31. Platelet Rich Plasma Market Other Major and Innovative Companies
35. Platelet Rich Plasma Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Platelet Rich Plasma Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on platelet rich plasma market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for platelet rich plasma ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The platelet rich plasma market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Pure Platelet Rich Plasma; Leukocyte-Rich Platelet Rich Plasma; Leukocyte-Rich Fibrin; Other Types2) By Origin: Allogeneic Platelet Rich Plasma; Autologous Platelet Rich Plasma; Homologous Platelet Rich Plasma
3) By Application: Cosmetic Surgery and Aesthetics; General Surgery; Neurosurgery; Orthopedic and Spinal Surgery; Other Applications
4) By End User: Hospitals and Clinics; Research Institutes; Other End-Users
Subsegments:
1) By Pure Platelet Rich Plasma: Low Concentration PRP; High Concentration PRP2) By Leukocyte-Rich Platelet Rich Plasma: Autologous LR-PRP; Allogeneic LR-PRP
3) By Leukocyte-Rich Fibrin: Injectable Leukocyte-Rich Fibrin; Membrane Leukocyte-Rich Fibrin
4) By Other Types: Platelet Rich Fibrin (PRF); Concentrated Platelet-Rich Plasma (cPRP); Platelet-Poor Plasma (PPP)
Key Companies Mentioned: Johnson & Johnson Services Inc.; Stryker; Zimmer Biomet; Terumo Corporation; Arthrex Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
The major companies featured in this Platelet Rich Plasma market report include:- Johnson & Johnson Services Inc.
- Stryker
- Zimmer Biomet
- Terumo Corporation
- Arthrex Inc.
- Pall Corporation
- Globus Medical
- LifeNet Health
- Exactech Inc.
- BioBridge Global
- Regen Lab SA
- Celling Biosciences Inc.
- Eclipse Aesthetics LLC
- Regenexx
- Isto Biologics
- Royal Biologics
- Apex Biologix
- EmCyte Corporation
- Medira Ltd.
- Nuo Therapeutics Inc.
- Juventix Regenerative Medical LLC.
- Estar Medical
- Dr PRP USA LLC
- MDBiologix
- Vivostat A/S
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 200 |
Published | April 2025 |
Forecast Period | 2025 - 2029 |
Estimated Market Value ( USD | $ 0.83 Billion |
Forecasted Market Value ( USD | $ 1.57 Billion |
Compound Annual Growth Rate | 17.2% |
Regions Covered | Global |
No. of Companies Mentioned | 26 |